Loading...
Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review
Immune checkpoint inhibitors (ICIs) belong to a new group of anticancer drugs targeting T-cell proteins involved in the activation of immune response toward malignancies. Their introduction into clinical practice was a milestone in modern cancer treatment. However, the significant advantage of ICIs...
Na minha lista:
Main Authors: | , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Bioscientifica
2020-10-01
|
Serier: | Endocrine Connections |
Fag: | |
Online adgang: | https://ec.bioscientifica.com/view/journals/ec/9/10/EC-20-0342.xml |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|